Literature DB >> 11891780

Effects of cytokine deficiency on chemokine expression in CNS of mice with EAE.

Agata Matejuk1, Jami Dwyer, Atsushi Ito, Zachary Bruender, Arthur A Vandenbark, Halina Offner.   

Abstract

Although both cytokines and chemokines have been implicated in the pathogenesis of clinical and histological EAE, their interactions in vivo have not yet been clearly established. To address this issue, we evaluated expression of chemokines and receptors in the CNS of wild-type control and cytokine deficient mice at the peak of EAE induced with MOG-35-55 peptide in CFA. Our results demonstrate that: 1) expression of most chemokines/receptors was drastically inhibited in TNF-alpha deficient mice, and was reflective of delayed onset and reduced severity of EAE; 2) distinct patterns of chemokine expression occurred in various other cytokine knockout mice that did not significantly affect expression of clinical EAE; 3) there was a strong association between expression of MIP-1alpha, MIP-2 and MCP-1 in CNS and overall severity of EAE in wild-type and cytokine knockout mice; and 4) among CNS infiltrating cells at the peak of EAE, macrophages and CD8+ T cells were the primary cellular source of most of the chemokines. Of note, we present evidence that TNF-alpha may be involved in regulating RANTES and MIP-1alpha, and that IL-4 may be involved in regulating MCP-1. Our results not only identify the cellular source of chemokines in CNS, but also implicate MIP-1alpha, MIP-2, and MCP-1 in controlling CNS inflammation and severity of EAE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891780     DOI: 10.1002/jnr.10156

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases.

Authors:  Alla L Zozulya; Emily Reinke; Dana C Baiu; Jozsef Karman; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

2.  Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.

Authors:  Asgar Zaheer; Shailendra K Sahu; Yanghong Wu; Ashna Zaheer; Joel Haas; Kiwhoon Lee; Baoli Yang
Journal:  Brain Res       Date:  2007-01-27       Impact factor: 3.252

3.  Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.

Authors:  R Pattarini; R J Smeyne; J I Morgan
Journal:  Neuroscience       Date:  2007-01-29       Impact factor: 3.590

4.  Regulator of G-protein Signaling (RGS)1 and RGS10 Proteins as Potential Drug Targets for Neuroinflammatory and Neurodegenerative Diseases.

Authors:  Jae-Kyung Lee; Josephine Bou Dagher
Journal:  AAPS J       Date:  2016-02-22       Impact factor: 4.009

5.  A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system is required for inflammatory infiltration of the spinal cord.

Authors:  Mary Ann Gimenez; Julia Sim; Angela S Archambault; Robyn S Klein; John H Russell
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

6.  Blockade of the kinin B1 receptor affects the cytokine/chemokine profile in rat brain subjected to autoimmune encephalomyelitis.

Authors:  Karolina Podsiadło; Grzegorz Sulkowski; Beata Dąbrowska-Bouta; Lidia Strużyńska
Journal:  Inflammopharmacology       Date:  2017-02-03       Impact factor: 4.473

7.  The "window of susceptibility" for inflammation in the immature central nervous system is characterized by a leaky blood-brain barrier and the local expression of inflammatory chemokines.

Authors:  Lucia Schoderboeck; Milena Adzemovic; Eva-Maria Nicolussi; Claudia Crupinschi; Sonja Hochmeister; Marie-Therese Fischer; Hans Lassmann; Monika Bradl
Journal:  Neurobiol Dis       Date:  2009-06-09       Impact factor: 5.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.